CMRA
Comera Life Sciences Holdings, Inc.
Set alert
0.00 USD 0.00 0.00%
0.0001 Day range 0.0001
0.0001 52-week range 0.0001
- YTD
- 0.00%
- 1 year
- 0.00%
- Open
- 0.0001
- Prev close
- 0.0001
- Mkt cap
- 3.07K
- Vol
- 730
- Avg vol
- 501
- EPS
- -0.11
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.0001
- High
- 0.0001
- Forward P/E
- 0.00
- Beta
- 0.45
- Short ratio
- 0.84
- Inst. own
- 13.56%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.21206
- 200-d avg
- 0.542355
- 1y target
- 0.00
Financial health
Altman Z-Score
-28.11 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -0.7×
FY 2020 5y median -34.9× FY 2022
P/S 20.3×
FY 2020 5y median 444× FY 2022
P/B -2.1×
FY 2020 5y median 31.3× FY 2022
P/FCF -1.3×
FY 2020 5y median -49.6× FY 2022
EV/EBITDA -0.7×
FY 2020 5y median -34.9× FY 2022
EV/Sales 20.8×
FY 2020 5y median 444× FY 2022
FCF Yield -76.2%
FY 2020 5y median -2.0% FY 2022
Profitability
Gross Margin 66.8%
FY 2020 5y median 66.8% FY 2022
Operating Margin -1890.7%
FY 2020 5y median -1730.8% FY 2022
Net Margin -2843.8%
FY 2020 5y median -1704.6% FY 2022
ROE 288.2%
FY 2020 5y median -88.3% FY 2022
ROIC 1768.6%
FY 2020 5y median -85.2% FY 2022
ROA -483.1%
FY 2020 5y median -389.4% FY 2022
Growth (YoY)
Revenue 97.9%
FY 2020 FY 2022
Operating Income -116.2%
FY 2020 FY 2022
EPS (diluted) -506.9%
FY 2020 FY 2022
Free Cash Flow -151.3%
FY 2020 FY 2022
Financial Health
Current Ratio 0.6×
FY 2020 5y median 1.3× FY 2022
Quick Ratio 0.6×
FY 2020 5y median 1.2× FY 2022
Debt / Equity -0.1×
FY 2020 5y median 0.1× FY 2022
Net Debt / EBITDA -0.0×
FY 2020 5y median -0.0× FY 2022
Interest Coverage -587×
FY 2020 5y median 0.0× FY 2022
Dividends
Dividend Yield 0.0%
FY 2020 5y median 0.0% FY 2022
Payout Ratio 0.0%
FY 2020 5y median 0.0% FY 2022
Annual · latest fiscal year ends 2022-12-31